Tech Company Financing Transactions

Myosana Therapeutics Funding Round

Myosana Therapeutics, based in Seattle, secured $1 million in funding from CureDuchenne Ventures.

Transaction Overview

Announced On
4/23/2020
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Seed
Investors

CureDuchenne Ventures (Debra Miller)

Proceeds Purpose
Myosana will use this initial funding to advance development of its innovative non-viral gene therapy to deliver full length dystrophin for Duchenne muscular dystrophy (DMD).

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2617 Nw 59th St. 102
Seattle, WA 98107
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Myosana Therapeutics, Inc. is leading the efforts in developing new gene therapies that will slow skeletal muscle degeneration and heart failure to improve the quality of life, increase longevity and reduce the disease burden of Duchenne muscular dystrophy (DMD) and other neuromuscular diseases.
Profile
Myosana Therapeutics LinkedIn Company Profile
Social Media
Myosana Therapeutics Company Twitter Account
Company News
Myosana Therapeutics News
Facebook
Myosana Therapeutics on Facebook
YouTube
Myosana Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Stan Froehner
  Stan Froehner LinkedIn Profile  Stan Froehner Twitter Account  Stan Froehner News  Stan Froehner on Facebook
Chief Executive Officer
Steve Runnels
  Steve Runnels LinkedIn Profile  Steve Runnels Twitter Account  Steve Runnels News  Steve Runnels on Facebook
Chief Scientific Officer
Nick Whitehead
  Nick Whitehead LinkedIn Profile  Nick Whitehead Twitter Account  Nick Whitehead News  Nick Whitehead on Facebook
VP - R & D
Min Kim
  Min Kim LinkedIn Profile  Min Kim Twitter Account  Min Kim News  Min Kim on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/23/2020: Hone venture capital transaction
Next: 4/23/2020: Bodhala venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary